Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R A Linker

Showing results (1-10 of 27) with videos related to

Pageof 3
Sort By:
Der Nervenarzt|February 20, 2015
[Do new oral therapies show advantages in the basal therapy of multiple sclerosis? Con]R A Linker
Der Nervenarzt|March 9, 2018
[Nutrition, microbiome and multiple sclerosis : Current knowledge from basic research and clinical practice]A Haghikia, R A Linker
Der Nervenarzt|September 23, 2008
[Choice of early and escalation treatment options for multiple sclerosis]R A Linker, B C Kieseier
Clinical Immunology (Orlando, Fla.)|March 19, 2011
Fumaric acid and its esters: an emerging treatment for multiple sclerosis with antioxidative mechanism of actionR Gold, R A Linker, M Stangel
Revue Neurologique|July 4, 2007
Termination of inflammation in the nervous systemR Gold, R A Linker, A Chan
Gene|October 17, 1996
Cloning of the murine relA (p65 NF-kappa B) gene and comparison to the human gene reveals a distinct first intronR A Linker, P A Baeuerle, C Kaltschmidt
Current Neuropharmacology|September 2, 2009
Fumaric Acid and its esters: an emerging treatment for multiple sclerosisD Moharregh-Khiabani, R A Linker, R Gold, et al.
Der Nervenarzt|January 23, 2008
[Fumaric acid and its esters in the treatment of multiple sclerosis: studies and effects]M Stangel, D Moharregh-Khiabani, R A Linker, et al.
European Journal of Neurology|October 27, 2018
Diagnostic value of the 2017 McDonald criteria in patients with a first demyelinating event suggestive of relapsing-remitting multiple sclerosisD-H Lee, M Peschke, K S Utz, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|February 8, 2006
Core hypothermia in multiple sclerosis: case report with magnetic resonance imaging localization of a thalamic lesionR A Linker, A Mohr, L Cepek, et al.
Pageof 3

Showing results (1-10 of 27) with videos related to

Sort By:
Pageof 3
Der Nervenarzt|February 20, 2015
[Do new oral therapies show advantages in the basal therapy of multiple sclerosis? Con]R A Linker
Der Nervenarzt|March 9, 2018
[Nutrition, microbiome and multiple sclerosis : Current knowledge from basic research and clinical practice]A Haghikia, R A Linker
Der Nervenarzt|September 23, 2008
[Choice of early and escalation treatment options for multiple sclerosis]R A Linker, B C Kieseier
Clinical Immunology (Orlando, Fla.)|March 19, 2011
Fumaric acid and its esters: an emerging treatment for multiple sclerosis with antioxidative mechanism of actionR Gold, R A Linker, M Stangel
Revue Neurologique|July 4, 2007
Termination of inflammation in the nervous systemR Gold, R A Linker, A Chan
Gene|October 17, 1996
Cloning of the murine relA (p65 NF-kappa B) gene and comparison to the human gene reveals a distinct first intronR A Linker, P A Baeuerle, C Kaltschmidt
Current Neuropharmacology|September 2, 2009
Fumaric Acid and its esters: an emerging treatment for multiple sclerosisD Moharregh-Khiabani, R A Linker, R Gold, et al.
Der Nervenarzt|January 23, 2008
[Fumaric acid and its esters in the treatment of multiple sclerosis: studies and effects]M Stangel, D Moharregh-Khiabani, R A Linker, et al.
European Journal of Neurology|October 27, 2018
Diagnostic value of the 2017 McDonald criteria in patients with a first demyelinating event suggestive of relapsing-remitting multiple sclerosisD-H Lee, M Peschke, K S Utz, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|February 8, 2006
Core hypothermia in multiple sclerosis: case report with magnetic resonance imaging localization of a thalamic lesionR A Linker, A Mohr, L Cepek, et al.
Pageof 3